Chen X - Search Results

1

Randomized, double-blind, placebo-controlled phase III study of ixazomib plus lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma: China Continuation study.

Hou J, Jin J, Xu Y, Wu D, Ke X, Zhou D, Lu J, Du X, Chen X, Li J, Liu J, Gupta N, Hanley MJ, Li H, Hua Z, Wang B, Zhang X, Wang H, van de Velde H, Richardson PG, Moreau P. Hou J, et al. Among authors: chen x. J Hematol Oncol. 2017 Jul 6;10(1):137. doi: 10.1186/s13045-017-0501-4. J Hematol Oncol. 2017. PMID: 28683766 Free PMC article. Clinical Trial.

2

[A multi-centers clinical study of different treatment outcomes of 332 patients with multiple myeloma].

Xue K, Qiu LG, Liu T, Hou J, Huang XJ, Ma J, Chen XQ, Yu L, Jin J, Wu DP, Wu YJ, Meng FY, Li JY, Chen WM, Wang C, Wang JM, Huang ZL, Zou P, Lou SF, Ouyang J, Zhou F, Du X, Shen ZX. Xue K, et al. Among authors: chen xq, chen wm. Zhonghua Nei Ke Za Zhi. 2008 Feb;47(2):98-101. Zhonghua Nei Ke Za Zhi. 2008. PMID: 18683792 Chinese.

3

[PAD regimen for relapsed or refractory patients with multiple myeloma].

Zhang YQ, Liang R, Bai QX, Zhang T, Yang L, Wang YW, Wang WQ, Gu HT, Shu MM, Zhu HF, Bai YN, Chen XQ. Zhang YQ, et al. Zhonghua Xue Ye Xue Za Zhi. 2009 Apr;30(4):260-3. Zhonghua Xue Ye Xue Za Zhi. 2009. PMID: 19731828 Chinese.

4

Different dose combinations of bortezomib and dexamethasone in the treatment of relapsed or refractory myeloma: an open-label, observational, multi-center study in China.

Yuan ZG, Jin J, Huang XJ, Li Y, Chen WM, Liu ZG, Chen XQ, Shen ZX, Hou J. Yuan ZG, et al. Chin Med J (Engl). 2011 Oct;124(19):2969-74. Chin Med J (Engl). 2011. PMID: 22040537 Clinical Trial.

5

Multicenter, randomized, open-label study comparing the efficacy and safety of micafungin versus itraconazole for prophylaxis of invasive fungal infections in patients undergoing hematopoietic stem cell transplant.

Huang X, Chen H, Han M, Zou P, Wu D, Lai Y, Huang H, Chen X, Liu T, Zhu H, Wang J, Hu J. Huang X, et al. Among authors: chen h, chen x. Biol Blood Marrow Transplant. 2012 Oct;18(10):1509-16. doi: 10.1016/j.bbmt.2012.03.014. Epub 2012 Mar 30. Biol Blood Marrow Transplant. 2012. PMID: 22469884 Free article. Clinical Trial.

6

A multicenter randomized controlled trial of recombinant human thrombopoietin treatment in patients with primary immune thrombocytopenia.

Wang S, Yang R, Zou P, Hou M, Wu D, Shen Z, Lu X, Li Y, Chen X, Niu T, Sun H, Yu L, Wang Z, Zhang Y, Chang N, Zhang G, Zhao Y. Wang S, et al. Among authors: chen x. Int J Hematol. 2012 Aug;96(2):222-8. doi: 10.1007/s12185-012-1124-8. Epub 2012 Jun 30. Int J Hematol. 2012. PMID: 22753022 Clinical Trial.

7

Prognostic power of abnormal cytogenetics for multiple myeloma: a multicenter study in China.

Lai YY, Huang XJ, Cai Z, Cao XS, Chen FP, Chen XQ, Chen BA, Fang MY, Feng JF, Fu WL, Guo HY, Hou M, Hou J, Hu Y, Hu XT, Hu XM, Huang LQ, Jin J, Li JY, Li J, Li W, Liang YM, Liu T, Liu QF, Liu YH, Mao P, Ouyang J, Qiu LG, Qiu L, Shao CK, Shi B, Song YP, Sun ZM, Wang QS, Wang C, Wang JM, Wang YS, Wang Z, Wu JB, Wu YX, Xia RX, Xue YQ, Yang BZ, Yang G, Yang ZL, Yu L, Yuan Z, Zhang S, Zhang Y, Zhao HG, Zhao L, Zhou DB, Zou SH, Zhu YF. Lai YY, et al. Chin Med J (Engl). 2012 Aug;125(15):2663-70. Chin Med J (Engl). 2012. PMID: 22931972

8

[Efficacy comparison between standard and reduced doses of bortezomib combined with adriamycin and dexamethasone in the treatment of patients with multiple myeloma].

Gu HT, Shu MM, Gao GX, Dong BX, Liang R, Yang L, Bai QX, Zhang T, Zhang YQ, Chen XQ. Gu HT, et al. Zhonghua Xue Ye Xue Za Zhi. 2013 Jul;34(7):622-5. doi: 10.3760/cma.j.issn.0253-2727.2013.07.014. Zhonghua Xue Ye Xue Za Zhi. 2013. PMID: 23906459 Chinese.

9

Posaconazole vs. fluconazole as invasive fungal infection prophylaxis in China: a multicenter, randomized, open-label study.

Shen Y, Huang XJ, Wang JX, Jin J, Hu JD, Yu K, Wu DP, Wang SJ, Yu L, Chen XQ, Liu T, Liang YM, Chen FP, Li Y, Shen ZX. Shen Y, et al. Int J Clin Pharmacol Ther. 2013 Sep;51(9):738-45. doi: 10.5414/CP201880. Int J Clin Pharmacol Ther. 2013. PMID: 23924680 Clinical Trial.

10

Modified bortezomib, adriamycin and dexamethasone (PAD) regimen in advanced multiple myeloma.

Zhang Y, Liu H, Chen X, Bai Q, Liang R, Shi B, Liu L, Tian D, Liu M. Zhang Y, et al. Among authors: chen x. Pathol Oncol Res. 2014 Oct;20(4):987-95. doi: 10.1007/s12253-014-9785-7. Epub 2014 Jun 19. Pathol Oncol Res. 2014. PMID: 24942506 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

115,374 results

Search Page

Filters